A favorable effect of hydroxychloroquine on glucose and lipid metabolism beyond its anti-inflammatory role
I wanted to throw this in first. This is the type straightforward research paper that you find when those writing it are not paid off by Big Pharma.
Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflict of interest statement: The authors declare no conflicts of interests.
“Hydroxychloroquine (HCQ), a commonly used antimalarial drug in rheumatic diseases, has shown favorable metabolic effects on both glucose control and lipid profiles.”
“HCQ as a treatment for her Sjogren syndrome in addition to a subtle yet measurable improvement in her lipid profile. An increasing body of evidence supports the beneficial impacts of HCQ in various ancillary conditions, including diabetes mellitus and dyslipidemia.”
“In September 2011, she was diagnosed with Sjogren syndrome and was started on HCQ 200 mg once daily. An improvement in her glycemic control as evidenced by self glucose monitoring was noted within 1 month of HCQ therapy, with no remarkable hypoglycemic episodes. Her glycated hemoglobin A1C (HbA1C) was successfully reduced to target in January 2011.”
“After reviewing the literature, our case seems to be the first case report of a patient with type 1 diabetes who had improvement in her glycemic control while on HCQ therapy.”
“Antimalarials and effects on glucose metabolism; the antidiabetic effect of chloroquine (CQ) was first described in 1984 in a patient with severe insulin resistance in whom the addition of CQ dramatically reduced his insulin requirements.”
“Similarly, patients with sulfonylurea-refractory type 2 diabetes mellitus (T2DM), treated with HCQ, demonstrated an improvement in their glycemic control during the first 6 months of therapy with a reduction of 1.02% in their HbA1C compared with placebo [95% confidence interval.”
“The patient had a subsequent decrease in his insulin requirements by 37% [Shojania et al. 1999]. Another report emphasizing the glucose-lowering effect of HCQ is that describing a case of hypoglycemia in a patient with SLE and T2DM after initiation of HCQ at a dose of 200 mg twice daily with eventual discontinuation of her subcutaneous insulin.”
“Besides its glucose-lowering effect in patients with diabetes, lower fasting blood sugar levels [Penn et al. 2010], as well as hypoglycemia have also been reported with CQ and HCQ in subjects without diabetes.”
” Interestingly, HCQ lowers the incidence of developing diabetes mellitus. In a retrospective cohort of 1127 patients with RA, the use of HCQ was associated with a 71% reduction in the risk of incident diabetes [hazard ratio (HR) 0.29; 95% CI 0.09–0.95; p = 0.04]”
“Demonstrated a 77% reduced incidence of diabetes in patients with RA who took HCQ for longer than 4 years, after adjustment for risk factors of diabetes, disease activity and glucocorticoid use.”
“Similarly, another recent retrospective cohort of 13,905 patients with a diagnosis of either RA or psoriasis reported a lower incidence of diabetes among HCQ and tumor necrosis factor inhibitor users compared with other non-biological disease-modifying antirheumatic drugs (HR 0.54; 95% CI 0.36–0.80)”
“The mechanism by which HCQ works to improve glycemic control in patients with type 1 diabetes is not known and our case seems to be the first case report in the literature.”
“A possible reduction in islet-cell autoimmunity by HCQ could be the underlying mechanism since our patient has longstanding type 1 diabetes with no insulin reserve and an effect on insulin resistance is less likely to be the underlying mechanism that led to the improvement in glycemic control.”
“Interestingly, changes in lipoproteins can be detected as early as 3 months after antimalarial therapy.”
“Reductions up to 54% in triglycerides (TGs), TC and apolipoprotein CIII levels have been reported in HCQ users in 18 women with mild or inactive SLE compared with nonusers. Furthermore, in a large longitudinal study involving 1260 patients with SLE, the use of antimalarials was negatively correlated with TC (p < 0.0001)”
“In addition, in a prospective randomized trial, Mundor and colleagues reported an overall increase of 15% in HDL-C in HCQ users in a population of patients with RA after 12 months of therapy compared with a decrement of 12% in patients treated with gold (p = 0.006)”
“This case and review highlight the need to re-examine HCQ as a potential therapy for T2DM and consider its use especially in patients with rheumatism and diabetes.”
“Favorable lipid-lowering and antidiabetic properties of HCQ renders this drug an attractive medical option. Given the elevated cardiovascular risk associated with RA and SLE, the addition of HCQ to patients’ usual treatment could counteract the dyslipidemic effect of glucocorticoids, resulting in a potential minimization of atheroma progression and thus possibly lowering mortality due to cardiovascular diseases.”
“In conclusion, HCQ is a relatively safe and inexpensive medication and has a favorable glucose and lipid lowering effect that provides a rationale for its use in addition to its known benefits in rheumatic diseases.”
“Further studies are needed in patients with type 1 diabetes who receive HCQ treatment for other rheumatologic conditions to clarify the mechanism by which HCQ affects their glycemic control.”
Funding: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Conflict of interest statement: The authors declare no conflicts of interests.
https://journals.sagepub.com/doi/10.1177/2042018814547204
Being Type 2 diabetic myself, I’m very much interested in implementation of any promising cures into medical practice. I’m going to email this material you’ve published to doctors I know in in Sydney, Adelaide, Perth, and Cairns in Australia. Thank you very much for your fine work, Paul.
hey mark, glad you came by sir. thank you very much i really appreciate that. can you please let me know what those doctors say when you hear back from them. here is part 1 of the diabetes post
if you didnt see. looking forward to hearing back from you mark. take care buddy
https://qplusnews.com/hydroxychloroquine-cures-type-2-diabetes
Hello!
WWG1WGA!!
Loved this article and was going to send it to my Dad who has bad diabetes. I was wondering about the beginning when it said the girl was diagnosed in September of 2011 and her target was reached by Janurary of 2011? I’m sure it’s a typo, but that kind of thing really jumps at some people. Like my dad..lol Just pointing at it, thank you and God Bless! Trump 2020!
*January
good eye anthony. yeah its a typo in the study so i just copied the text straight over. im slowly starting to tell my dad about it too. nice and easy because if i make any big moves ill scare him away lol!
just in case you didnt see, here is part one of the Diabetes post. And im almost finished putting together a new one from indian studies. the have been prescribing HCQ over there since 2014.
https://qplusnews.com/hydroxychloroquine-cures-type-2-diabetes
Of course, Paul, I’ll let you know. I’m curious of their reaction myself.
Thanks for part 1. Take care, too.
So…the vaccines that our dear DJT is having prepared may be some kind of administration of HCQ for nearly all the diseases we now suffer from.
I met a retired pharmacist in France around 2010 who told me that the whole of medicine had become corrupt, and that when he trained there were only 22 illnesses with straightforward remedies (often to stop eating and drink ‘l’eau d’une bonne source’ water from a good spring) which could cure a lot, then there were plant extracts which the apothecary could prescribe and mix up. He was in a rage at how medicine had been hi-jacked. I thought him a little nutty at the time, but now…I would love to see him, apologise for dismissing much of what he said, hear more and ask him what he thinks of DJT.
I also read as a child that QE2 and the royals used only Homeopathic remedies. Quinine is amongst those precious vials.